354 filings
Page 5 of 18
NPORT-P
ipgs8rr4
13 May 21
None (Mar 2021 report)
4:01pm
8-K
pc91eb ivf82br
6 May 21
Other Events
10:12am
4
pn75o
19 Apr 21
DAXOR / Robert J Michel ownership change
3:14pm
4
yigjpa9atm7xsk472atg
16 Apr 21
DAXOR / Michael Richard Feldschuh ownership change
9:45pm
8-K
hsn58xzwv5s vhwbj7ru
15 Mar 21
Breakthrough Patent-pending Tracer Developed for Broad Use
10:39am
N-CEN
s2ux3g
15 Mar 21
Annual report (registered investment company)
6:07am
N-CSR
8kj5whb13 lov3
25 Feb 21
Certified annual shareholder report (management investment company)
5:26pm
NPORT-P
yg1f8omouq7syajil0wp
21 Oct 20
None (Sep 2020 report)
4:28pm
8-K
tl297iwbyr y5nwyc
5 Oct 20
Other Events
9:03am
S-8
vw6q65z23jtb9ck6
16 Sep 20
Registration of securities for employees
4:48pm
N-PX
m1rs5ix
1 Sep 20
Annual report of proxy voting record
12:00am
N-CSRS
ad8okbcyb3
21 Aug 20
Certified semi-annual shareholder report (management investment company)
5:23pm
4
9ahbql
3 Aug 20
DAXOR / of Joseph Feldschuh Estate ownership change
5:01pm
4
tnrv53d
3 Aug 20
DAXOR / Edward Feuer ownership change
5:00pm
3
wi5sn
3 Aug 20
DAXOR / of Joseph Feldschuh Estate ownership change
5:00pm
4
ksfjy
29 Jul 20
DAXOR / JAMES A LOMBARD ownership change
5:16pm
8-K
8nuzkbr
21 Jul 20
Daxor Corporation Announces Pricing of $7.0 Million Registered Direct Offering
8:43am
8-K
cjuul 8g7
16 Jul 20
Daxor Announces Prospective Randomized Control Trial at Duke University Medical Center to Guide Volume Treatment In Heart Failure Patients
9:02am
4
764fcae
15 Jul 20
DAXOR / MARTIN S WOLPOFF ownership change
7:01pm
8-K
075xu219ki1
15 Jul 20
Daxor Announces Initiation of First-of-It’s-Kind Multicenter BVA-100® Study in Hospitalized Patients with COVID-19
3:53pm